MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
About MapLight Therapeutics
MapLight Therapeutics offers a platform designed to discover and develop therapeutics for brain disorders. It combines single-cell transcriptomics and optogenetics to identify novel drug targets and develop effective therapies for brain disorders.
Company Facts
- Headquarters
- Palo Alto
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- ipo
- Total Funding
- $640,599,999
- Last Funding Type
- series_d
- Last Funding Date
- 2025-07-28
- Website
- maplightrx.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical
Social Links
Canonical: https://fsome.com/organization/maplight-therapeutics-51888 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.